Concepedia

LBP-20-VK2809, a Novel Liver-Directed Thyroid Receptor Beta Agonist, Significantly Reduces Liver Fat with Both Low and High Doses in Patients with Non-Alcoholic Fatty Liver Disease: A Phase 2 Randomized, Placebo-Controlled Trial

Rohit Loomba, Joel Neutel, Rizwana Mohseni, David W. Bernard, Randall Severance, Michael Dao, Satinder Saini, Carmen Margaritescu, Ken Homer, Brian Tran,

Journal of Hepatology · 2019 · 85 citations · 0 references

Concepts

PharmacyPharmacologyPharmacotherapyHepatic PharmacotherapyHepatic PathophysiologyLipid MetabolismLipid-lowering TherapyLiver DiseaseMetabolic Liver DiseaseWeight ManagementAlcoholic Liver Disease SteatosisHepatic Lipid AccumulationPlacebo-controlled Efficacy AssessmentSteatosis BiomarkersSteatosis Quantification